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Aims Caveolinopathies are a family of genetic disorders arising from alterations of the caveolin-3 (cav-3) gene. The T78M
cav-3 variant has been associated with both skeletal and cardiac muscle pathologies but its functional contribution,
especially to cardiac diseases, is still controversial. Here, we evaluated the effect of the T78M cav-3 variant on car-
diac ion channel function and membrane excitability.
....................................................................................................................................................................................................
Methods
and results
We transfected either the wild type (WT) or T78M cav-3 in caveolin-1 knock-out mouse embryonic fibroblasts
and found by immunofluorescence and electron microscopy that both are expressed at the plasma membrane and
form caveolae. Two ion channels known to interact and co-immunoprecipitate with the cav-3, hKv1.5 and hHCN4,
interact also with T78M cav-3 and reside in lipid rafts. Electrophysiological analysis showed that the T78M cav-3
causes hKv1.5 channels to activate and inactivate at more hyperpolarized potentials and the hHCN4 channels to ac-
tivate at more depolarized potentials, in a dominant way. In spontaneously beating neonatal cardiomyocytes, the ex-
pression of the T78M cav-3 significantly increased action potential peak-to-peak variability without altering neither
the mean rate nor the maximum diastolic potential. We also found that in a small cohort of patients with supraven-
tricular arrhythmias, the T78M cav-3 variant is more frequent than in the general population. Finally, in silico analysis
of both sinoatrial and atrial cell models confirmed that the T78M-dependent changes are compatible with a pro-
arrhythmic effect.
....................................................................................................................................................................................................
Conclusion This study demonstrates that the T78M cav-3 induces complex modifications in ion channel function that ultimately
alter membrane excitability. The presence of the T78M cav-3 can thus generate a susceptible substrate that, in con-
cert with other structural alterations and/or genetic mutations, may become arrhythmogenic.
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1. Introduction
Many cellular processes require a concerted and ordered activation of
various proteins and signal transduction pathways; to comply with this
function, many proteins have been confined to specific membrane
microdomains that keep them in close proximity and favour their func-
tional interactions. Caveolae are specialized omega-shaped microdo-
mains localized in the plasma membrane of many cell types.1 In
cardiomyocytes, caveolae compartmentalize several ion channels, acces-
sory subunits, and modulatory proteins, whose contributions shape the
excitability properties of the plasma membrane. Important structural
components of caveolae are caveolins. In humans, three different iso-
forms of caveolin are expressed: caveolin-1 is ubiquitous, caveolin-2 usu-
ally interacts with caveolin-1, while caveolin-3 (cav-3) is the main
isoform expressed in muscles.1 Cav-3 binds several proteins including
ion channels and modulates their functional properties through this
interaction.2 We and others have previously demonstrated that alter-
ation of caveolar domains significantly affects the properties of cardiac
HCN4, Kv1.5, Cav1.2, and Nav1.5 channels.3–6
The term caveolinopathies identifies a family of diseases arising from
mutations in the cav-3 gene (CAV3). Several variants of CAV3 have
been reported in patients with skeletal muscle pathologies such as
limb-girdle muscular dystrophy (LMGD), rippling muscle disease
(RMD), isolated hyperCKemia and distal myopathy as well as in pa-
tients with cardiac pathologies such as long QT syndrome (LQTS),
sudden infant death syndrome (SIDS) and hypertrophic cardiomyop-
athy (HCM).7 The 233C > T variant introducing the amino acid substi-
tution T78M has been identified in patients with RMD, proximal
myopathy, LQTS, idiopathic hyperCKemia, and SIDS.8–12 A patient
homozygous for the T78M substitution presented both dilated cardi-
omyophaty, hyperCKemia, and proximal myotonia.10 In vitro func-
tional analysis demonstrated that expression of the T78M cav-3
causes changes in the Nav1.5 sodium channel properties, generating a
non-inactivating late INa
9 and a large reduction of the current density
generated by the Kir2.1 potassium channel.13 Even if these findings
point to a role of the T78M variant in generating the above patho-
logical phenotypes, recent analysis reported however this same vari-
ant in the general (healthy) population at a frequency comparable
to that found in LQTS patients.14–16 It thus remains unclear if and
how this single variant can generate such different phenotypes.
Considering that some cardiac arrhythmias may remain asymptom-
atic for years, the effect of the T78M substitution in contributing to a
pathological phenotype remains unresolved. To shed light on the
possible involvement of the T78M cav-3 variant in altering membrane
excitability, we analysed (1) the presence of caveolae in cells lacking
caveolins but transiently expressing this variant, (2) the interaction
and effect of the T78M cav-3 on the properties of heterologously ex-
pressed human (h)HCN4 and hKv1.5 channels, and (3) its effect on
membrane excitability in spontaneously beating neonatal rat ven-
tricular cardiomyocytes (NRVCs).
2. Methods
For detailed methods, see the Supplementary material online.
All animal procedures were in accordance with the Italian and UE
laws (D. Lgs n 2014/26, 2010/63/UE) and approved by the committee of
the Universita degli Studi di Milano and by the Italian Minister of Health
(protocol number 1197/2015).
2.1 Cell culture and transfection
For electrophysiological recordings and sucrose gradient fractionation
experiments, mouse embryonic fibroblasts from cav-1 knock-out mice
(3T3 MEF-KO CRL-2753TM, ATCC) plated in 35 mm dishes were co-
transfected with 1.5 mg of either WT or T78M cav-3, or with 0.75 mg of
both, and 1 mg of plasmid containing the ion channel sequence (hHCN4,
hKv1.5, hKir2.1) with Fugene HD or ViaFectTM Transfection Reagent
(Promega). Neonatal rat (sprague dawley, ENVIGO) ventricular cardio-
myocytes were isolated as previously described17 and transfected the
day after with the plasmid containing either the WT or the T78M cav-3
using Lipofectamine 2000 (Life Technologies).
For immunofluorescence or electron microscopy, MEF-KO cells
were transfected with 1.5 mg of either the WT-EGFP or T78M-EGFP
cav-3. For immunofluorescence cells were transfected also with 1 mg of
a mixture of pECFP-Mem and pECFP-C1-CAAX plasmids in order to
uniformly stain the entire membrane.
For co-immunoprecipitation experiments, MEF-KO cells plated on
60 mm dishes were transiently co-transfected with equimolar quantities
of the plasmid containing the ion channel sequence (V5-hKv1.5 or
hHCN4) and WT or T78M cav-3-EGFP plasmids with ViaFectTM
Transfection Reagent (Promega).
2.2 Electron microscopy and
immunofluorescence analysis
24–36 h after transfection, MEF-KO cells expressing either the WT or
T78M cav-3-EGFP were selected by flow cytometry (FACSAria II, BD)
and subsequently plated on 60 mm dishes, fixed, pelleted, and processed
for electron microscopy experiments.
For immunofluorescence analysis WT or T78M cav-3-EGFP and
membrane CFP signals were analysed in living cells; images were
acquired using a laser confocal microscope (Zeiss LSM710).
2.3 Separation of lipid raft membrane
fractions
Discontinuous sucrose gradient experiments were carried out as previ-
ously reported (see Supplementary material online and Refs. 3, 18).
2.4 Co-immunoprecipitation (co-IP)
24–36 h after transfection, MEF-KO cells were re-suspended in co-IP
buffer and supernatants were immunoprecipitated overnight at 4 C,
using anti-cav-3 antibody (Becton Dickinson). Anti-mouse DynabeadsVR
(Life Technologies) were used to bind. After elution and denaturation,
proteins were run on SDS-PAGE and revealed by western blotting using
specific antibodies (see Supplementary material online). All co-IP runs
were repeated at least twice.
2.5 Electrophysiology
Patch-clamp experiments in the whole-cell configuration were carried
out 36–48 h after transfection. MEF-KO cells or cardiomyocytes were
enzymatically dissociated and seeded at low density in order to analyse
ionic currents from single cells in voltage-clamp mode. Cardiomyocytes
were kept at 36 ± 1 C while MEF-KO cells were kept at room tempera-
ture. Action potentials were recorded using current-clamp mode from
small spontaneously beating clusters of transfected (fluorescent) cardio-
myocytes (3–5 cells) obtained by dissociation of the beating monolayer.
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..2.6 Genetic analysis
The investigation conforms with the principles outlined in the
Declaration of Helsinki. For caveolin-3 gene screening, approval was
granted by ethic review board of the University of Milan. Written in-
formed consent was obtained from the patients or parents prior to car-
rying out genetic analysis on genomic DNA extracted from whole blood
or saliva (Puragene Blood Kit, Qiagen). The coding sequence of CAV3
was amplified by PCR using specific primers. Analysis of the amplicons
was carried out by DNA sequencing (Bio-Fab Research).
2.7 Computational analysis
The effect of the T78M cav-3 variant on the cellular electrical activity
was estimated for both atrial and sinoatrial node (SAN) cell models.
Simulations of human atrial action potential were based on the Grandi-
Bers model19 and on the Koivumaki model.20 Since a full computational
model of human SAN cell is not currently available, the analysis of T78M
cav-3 effects on SAN action potentials was based on the Severi-
DiFrancesco model of rabbit SAN action potential.21 All numerical simu-
lations and data analysis were performed in Matlab (Mathworks Inc.).
2.8 Statistical analysis
Nested and One-Way ANOVA, followed by Fisher LSD mean compari-
son, were used to compare multiple groups (see Supplementary material
online); Student’s t-test for independent populations was used to
compare two groups. Fisher’s exact test was used to compare the fre-
quency of the T78M variant in specific subgroups vs. the general popula-
tion. Significance level was set to P= 0.05.
3. Results
3.1 T78M cav-3 reaches the plasma mem-
brane, forms caveolae and interacts with
ion channels
We first analysed the cellular distribution of the WT and T78M cav-3 in
MEF-KO cells, which lack endogenous caveolins22 and caveolae (Figure
1B, left), to evaluate whether the T78M cav-3 reaches the plasma mem-
brane or is retained in intracellular compartments, as reported for other
cav-3 variants.10 We co-transfected MEF-KO cells with a mix of two
plasmids able to target the CFP protein to both caveolar and non-
caveolar fractions of the plasma membrane and with either WT (Figure
1A, top) or T78M (Figure 1A, bottom) cav-3 fused to EGFP. Confocal
images show that both the WT and the T78M cav-3 are expressed at the
plasma membrane.
Subsequently, we evaluated if the T78M cav-3 forms caveolae. In
Figure 1B, representative electron microscopy images of MEF-KO cells
expressing either the WT (middle panel) or T78M (right panel) cav-3
are shown. While non-transfected MEF-KO cells do not show any visible
Figure 1 WT and T78M cav-3 proteins are expressed at the plasma membrane and form caveolae. (A) Representative confocal images of MEF-KO cells
co-transfected with either the WT-EGFP cav-3 (green, top left) or the T78M-EGFP cav-3 (green, bottom left) and the membrane-targeted CFP (pm, red,
centre) (exp = 3). Right panels show both signals overlapped (yellow). Scale bar = 20 mm. (B) Representative transmission electron micrographs of thin-sec-
tions from non-transfected (NT) MEF-KO cells (left) showing absence of any visible caveola, and from MEF-KO cells transfected with either the WT-EGFP
cav-3 (centre) or the T78M-EGFP cav-3 (right) in which typical caveolar structures (arrows) can be seen at the plasma membrane (pm). The inset in the first
panel shows a magnified region in which a clathrin-coated vesicle (Clv) is visible. rer, rough endoplasmic reticulum; N, nucleus; G, golgi apparatus; M, mito-
chondrion; n/exp = 25/3). Scale bar =150 nm.
1258 G. Campostrini et al.
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caveola (Figure 1B, left), caveolae could be detected in cells expressing
both cav-3 variants (arrows). A quantification analysis demonstrated that
the number of caveolae generated by expressing either the WT or
T78M cav-3 were similar (WT: 0.056 ± 0.007 cav/mm n= 25, T78M:
0.053 ± 0.006 cav/mm n= 25, from 3 experiments).
We then evaluated whether the T78M variant is present in lipid rafts
when membranes are separated based on their density, as previously re-
ported for the WT cav-3.3 We co-transfected MEF-KO cells with either
the WT or T78M cav-3 and either the hKv.1.5 or hHCN4, two ion chan-
nels that directly interact with cav-3.4,22–24 Figure 2A shows that both the
WT and T78M cav-3 reside in the lipid rafts together with hKv1.5 and
hHCN4. Furthermore, by co-immunoprecipitation experiments, we
evaluated if the T78M variant retains the capacity to interact with these
channels. Representative blots in Figure 2 show that both hHCN4 (panel
B) and hKv1.5 channels (panel C) co-immunoprecipitate with the WT
cav-3 isoform, as previously reported,22,23 and also with T78M cav-3,
demonstrating that the point mutation does not disrupt the molecular
complex formed by caveolins and these channels.
3.2 Effects of the T78M cav-3 on hKv1.5 and
hHCN4 channel properties
We next evaluated whether T78M cav-3 induces alterations of the ion
currents mediated by hKv1.5 or hHCN4 channels. We compared the
properties of these channels co-expressed in MEF-KO cells with either
the WT or the T78M cav-3. In panels A and B of Figure 3, families of
hKv1.5 current traces recorded from MEF-KO cells transfected with the
WT (top), the T78M (middle) or both variants (bottom) of cav-3, to
mimic heterozygous conditions, are shown. The plot of the mean activa-
tion curves (panel C top) shows that hKv1.5 activated at more negative
voltages when expressed with the T78M (empty circles) than with the
WT cav-3 (filled circles); the shift was 4 mV and was statistically signifi-
cant. Notably, the expression of equal amounts of WT and T78M cav-3
(WT/T78M, half-filled circles) had an effect similar to that of the T78M
cav-3 alone, with a shift of 3.6 mV vs. WT cav-3, suggesting a dominant
behaviour.
A similar negative shift was also evident from the analysis of inactiva-
tion curves (Figure 3C, middle); with shifts of 5.0 and 5.6 mV for homo-
meric T78M and heteromeric WT/T78M vs. WT cav-3, respectively,
(P< 0.05). hKv1.5 current densities were similar in all groups over the
whole range of voltages tested (Figure 3C, bottom).
In Figure 4A, normalized hHCN4 current traces, recorded in response
to a double step protocol to –85 and –125 mV from MEF KO cells trans-
fected with the WT, the T78M or both (WT/T78M) cav-3 isoforms, are
shown. In cells expressing the T78M variant, the fact that at –85 mV the
current is larger while at the fully activated voltage of –125 mV the steady
state current is similar indicates that hHCN4 activates at more positive
potentials than in WT cells. The analysis of the mean activation curves
shown in Figure 4B confirmed that co-expression of hHCN4 channels
with the T78M cav-3, either alone or together with the WT cav-3, signifi-
cantly shifted the hHCN4 channel activation to the depolarized direc-
tion, relative to co-expression with WT cav-3, by 7.9 and 8.8 mV,
Figure 2 The T78M cav-3 interacts with hHCN4 and hKv1.5 channels and targets them to lipid rafts. (A) Blots showing that hHCN4, hKV1.5, and cav-3
transfected in MEF-KO cells localize into lipid rafts isolated by discontinuous sucrose gradient (n>_ 2). Lys, lysate; LR lipid raft fractions; NLR non-lipid raft
fractions. (B, C) Co-immunoprecipitation (co-IP) experiments from MEF-KO cells co-transfected with either HCN4 (B) or V5-Kv1.5 (C) and WT cav-3
EGFP or T78M cav-3 EGFP (n= 3). An aliquot of the input (in) and of the co-IP eluate (þ) were tested by western blot. A negative control (–) was per-
formed by omitting the cav-3 antibody in the IP procedure. The cav-3 signal appear at around 50 kDa because it is a fusion protein with EGFP. The band just
above the caveolin signal represents the heavy chain of the mouse IgG used during the immunoprecipitation, since it can be directly recognized by the anti-
mouse IgG secondary antibody used in the cav3 western blots (data not shown).
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..respectively. Since a depolarized shift of the hHCN4 current can result
from increases intracellular levels of cAMP, we evaluated if saturating
concentration of cAMP (10 mM) in the recording pipette shifted the acti-
vation curve of hHCN4 also in the presence of T78M cav-3. Figure 4C
shows the mean V1/2 recorded in the presence of cAMP (filled circles)
and in day-matched control measurements (empty circles) for the
hHCN4 co-expressed with the WT, T78M, and WT/T78M cav-3. It is
apparent that cAMP significantly shifted the V1/2 curves of hHCN4 chan-
nels to more depolarized potentials in all conditions. In the presence of
10 mM cAMP V1/2 values of HCN4 channels were similar. Neither cur-
rent densities (Figure 4D) nor time constants (not shown) were affected
by the cav-3 variant.
3.3 Effect of the T78M cav-3 on membrane
excitability
Taking advantage of the dominant effect of the T78M variant, we trans-
fected either the WT or the T78M cav-3 plasmids in primary cultures of
neonatal rat ventricular cardiomyocytes (NRVCs) which endogenously
express both cav-3 and cav-1,25 fire spontaneous action potentials and
express several types of cardiac ion channels and modulatory proteins.
As a readout of the expression of the T78M cav-3 variant in this system
we analysed the endogenous If current expressed by NRVCs. In agree-
ment with the hHCN4 data in MEF-KO cells, f-channels activated at sig-
nificantly more depolarized potentials in cardiomyocytes expressing the
T78M than in those expressing the WT cav-3 (see Supplementary ma-
terial online, Figure S1).
Even though data in the heterologous expression systems showed that
the T78M causes gain-of-function changes in both channels studied, the ef-
fect of the T78M cav-3 variant on the overall membrane excitability is diffi-
cult to predict. It is indeed known that caveolins functionally interact with
and modulate many proteins beyond ion channels.26 We thus directly eval-
uated whether the T78M variant can affect membrane excitability of NRVC.
Figure 5A shows representative traces of the time course of the inter-
beat interval (IBI) obtained from recordings of spontaneous activity from
NRVCs transfected with either the empty vector (top), the WT (middle),
or the T78M cav-3 (bottom). The insets represent stretches of original
action potential recordings. The presence of the T78M cav-3 increased
irregularities in spontaneous firing compared to NRVCs expressing the WT
cav-3. Notably, on average the T78M cav-3 expression did not alter the
Figure 3 The T78M cav-3 affects hKv1.5 channel properties. Representative current traces recorded from MEF-KO cells co-transfected with hKv1.5 and
WT cav-3 (top), T78M cav-3 (centre), or both (bottom) during activation (A) and inactivation voltage protocols (B). Insets in A show, on an expanded scale,
tail currents recorded at –50 mV used for activation curve analysis. (C) Mean activation curves (top; V1/2 values were: WT 1.41 ± 0.70 mV, n/exp = 27/13;
T78M –2.63 ± 1.43*, n/exp = 23/11; WT/T78M –2.21 ± 1.15*, n/exp = 17/5), inactivation curves (centre; WT –5.9 ± 0.9 mV, n/exp = 24/12; T78M –
10.9 ± 0.9*, n/exp = 24/11; WT/T78M –11.5 ± 0.6*, n/exp = 18/5) and current density-voltage relations (bottom, WT n/exp = 22/12, T78M n= 26/11, WT/
T78M n= 21/5) in the three groups (WT filled circles, T78M open circles, WT/T78M half-filled circles,) *P< 0.05 by nested and One-way ANOVA with
Fisher’s test.
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.mean IBI (Figure 5B), but caused a significant change only in the inter-beat
variability, calculated as the coefficient of variation (CV, Figure 5C).27 Mean
maximum diastolic potential (MDP) (Figure 5D) was not affected, while the
standard deviation of MDP was significantly higher in the presence of T78M
cav-3 (Figure 5E). These data indicate that expression of the T78M variant
can indeed cause minor but significant alterations of membrane excitability.
3.4 Population study and genetic analysis
Although data from the literature indicate that the minor allele frequency
(MAF) of the T78M variant is similar in the general population and in co-
horts of LQTS patients and SIDS,14,16 we have evaluated the MAF in
small cohorts of patients affected by other types of arrhythmias in which
HCN4 and Kv1.5 channels are involved.28,29 We screened the CAV3
gene in patients affected by: inappropriate sinus tachycardia (IST, 46 pa-
tients), sinus bradycardia (SB, 111 patients) and atrial fibrillation (AF, 16
patients). We also screened DNA samples from 37 stillbirths that did
not present mutations in the KCNQ1, KCNH2, and SCN5A genes, the
most prevalent LQT-linked genes found in stillbirths30 and from 209 un-
affected controls. We found the T78M (CAV3 233C > T) variant in 2 pa-
tients with AF, 4 patients with IST and in 2 stillbirths. Frequencies of the
T78M variant in these cohorts were thus significantly higher than those
found in the bradycardic population (1 patient), in our control popula-
tion (none) and in the general population, as reported in the ExAC data-
base and in previous works.14,16 Table 1 reports the allele frequency of
the T78M variant in these cohorts.
3.5 Computational modelling of the
T78M effect
Although the above data point to a deleterious effect of the T78M variant,
in order to gain insight into its possible role in generating a cellular sub-
strate susceptible to cardiac arrhythmias, we also adopted an in silico ap-
proach to verify the effects of the T78M variant by numerical modelling.
Since we found the T78M variant at high frequencies in patients with sinus
tachycardia as well as in patients with atrial fibrillation, we have used math-
ematical models of both atrial19 and sinoatrial21 action potentials (Figure 6).
In the top panel of Figure 6, the thin line represents the simulated ac-
tion potential of an atrial cell under control conditions, while the thick
line represents the action potential after the introduction of the T78M-
related alterations in the If and IKur currents described above and the al-
terations in the INa current previously reported.
9 It has also been
Figure 4 The T78M cav-3 alters hHCN4 channel voltage-dependence. (A) Representative current traces elicited by a double hyperpolarizing step protocol
to –85 and –125 mV (holding potential –35 mV) recorded from MEF-KO cells expressing hHCN4 and the WT, T78M or both forms of cav-3, as indicated; traces
were normalized and overlapped for comparison. (B) Mean hHCN4 activation curves (V1/2 values: WT –86.2 ± 1.1 mV, n/exp = 26/15; T78M –78.3 ± 1.1* mV,
n/exp =30/11; WT/T78M –77.4 ± 1.0* mV, n/exp =29/10. *P< 0.05 by nested and One-Way ANOVA with Fisher’s test), obtained from the different groups
(WT filled circles, T78M open circles; WT/T78M half-filled circles). (C) Mean V1/2 values from day-matched recordings of hHCN4 currents in control (CTRL,
empty circles) or in the presence of 10 mM cAMP in the pipette solution (þcAMP, black circles) in MEF-KO cells transfected with hHCN4 and WT, T78M or
both forms of cav-3, as indicated (WT, control: –84.1 ± 1.5 mV n/exp = 6/4, cAMP: –73.4 ± 1.5 mV n/exp = 11/4; T78M, control: –79.8 ± 1.5 mV n/exp = 8/3,
cAMP: –71.9 ± 1.0 mV n/exp = 16/3; WT/T78M, control: –77.8 ± 1.5 mV n/exp = 8/3, cAMP: –72.5 ± 1.6 mV n/exp = 8/3). *P< 0.05 by Student’s t-test. (D) Mean
current density-voltage relations are shown for comparison (WT, n/exp = 20/10; T78M, n/exp = 14/9; WT/T78M, n= 20/10).
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previously reported that the T78M mutation is associated with a de-
crease in the Kir2.1 current amplitude of about 70% at –80 mV.13
According to our numerical reconstruction, this decrease of Kir2.1 cur-
rent causes a large membrane depolarization incompatible with mem-
brane excitability (see Supplementary material online, Figure S2A). We
then checked the effects of the T78M mutation on either native IK1 cur-
rent in neonatal cardiomyocytes (data not shown) or on hKir2.1 chan-
nels expressed in MEF-KO cells (see Supplementary material online,
Figure S2B) but we did not observe any alteration. For these reasons, no
change in Kir2.1 current was included in our model.
Introducing then only the If and IKur changes described above, the
presence of the T78M mutation induced in the atrial action potential a
clear shortening of the duration (–11%) at both 50% and 90% of repolari-
zation (APD50 and APD90), a mild depolarization (2.3 mV) of the resting
potential and a reduction of the peak potential (–8.4 mV) (Figure 6).
Simulations were also repeated using an alternative computational
model of human atrial action potential20 and the results were similar to
those of the Grandi-Bers model (APD50 –7%, APD90 –13%, resting
potentialþ0.6 mV; peakþ0.1 mV; data not shown).
Simulation of the T78M effects using the Severi-DiFrancesco
model of a rabbit SAN cell shows, as expected, an increase in firing
rate (18%) due to an increase in the diastolic depolarization rate
(Figure 6, bottom), with only minor differences in other action poten-
tial parameters (APD90 –6%, Maximum Diastolic Potentialþ1 mV,
upstroke potential –3 mV).
In conclusion, our data show that the T78M variant is able to reach
the plasma membrane and to form caveolae. Nonetheless, the T78M
cav-3 modifies the properties of interacting cardiac channels in a way
able to produce alterations of the overall electrical activity of the
cardiomyocytes.
Figure 5 The electrical properties of NRVCs are altered in the presence of T78M cav-3. (A) Time course of the inter-beat interval (IBI) in neonatal cardio-
myocytes transfected with the empty vector (EV, top), the WT cav-3 (centre) or the T78M cav-3 (bottom) vectors; insets show 5 s stretches of the original
action potential recordings. Scatter plots showing single values (empty circles) and mean values (black circles) of (B) The IBI (EV 0.55 ± 0.04 s, n/exp = 7/2;
WT 0.61 ± 0.04 s, n/exp = 18/3; T78M 0.58 ± 0.05 s, n/exp = 9/3), (C) Coefficient of variation of the IBI (CVIBI; EV 0.14 ± 0.04; WT 0.12 ± 0.01; T78M
0.29 ± 0.03), (D) Maximum diastolic potential (MDP; EV –57.9 ± 5.2 mV; WT –52.6 ± 1.6 mV; T78M –55.1 ± 2.5 mV) and of (E) the MDP standard deviation
(SDMDP, EV 0.85 ± 0.21; WT 1.13 ± 0.12; T78M 2.41 ± 0.35). *P< 0.05 vs. all other conditions by nested and one-way ANOVA with Fisher’s test.
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4. Discussion
4.1 The T78M variant is found in the
general population and in patients with
rhythm disorders at different frequencies
Among the cav-3 variants, T78M is the one most frequently found in pa-
tients with cardiac and muscle diseases.7,12,31 For example, the T78M
mutation has been linked to LQTS,8 a pathology that can cause cardiac
arrest as a first symptom, and to some cases of SIDS.9 Studies suggesting
the association of the T78M variant with one or more pathological con-
ditions, however, do not normally provide evidence for functional al-
terations,10,11 with the exception of two studies9,13 showing that
expression of the T78M cav-3, in heterologous cellular systems, causes
pro-arrhythmogenic ion channel modifications. Cronk et al.9 have shown
a gain of function of the sodium channel Nav1.5 due to the increase of a
non-inactivating late component, while Vaidyanathan and colleagues13
have shown a loss of function of Kir2.1 channels responsible for the IK1
current that stabilizes the resting potential of working cardiomyocytes.
Lately however, genetic analysis has questioned the pathogenic role of
the T78M variant; Spadafora et al., reported that T78M cav-3 seems to
be a common polymorphism in South Italy,15 while others14,16 found the
T78M variant in a cohort of healthy controls with a MAF similar to that
found in both LQTS patients and SIDS and in agreement with data from
the Exome Sequencing Project. They thus argued against a causative ef-
fect of this cav-3 variant in the etiology of those conditions. It is import-
ant to underline, however, that the onset of cardiac pathologies occurs
mostly late in life and it is usually multifactorial (genetic predisposition,
prior diseases, lifestyle); under these conditions, a healthy control ap-
pears hard to define.
Here, we report the presence of the T78M variant in patients affected
by AF and IST and in stillbirths at a significantly higher frequency (from
2.7 to 6.7%) than in the general population (0.3%). Though an in-depth
genetic analysis is still lacking, our findings suggest that the T78M variant,
in association with other factors, may contribute to the development of
arrhythmic conditions.
4.2 The T78M variants normally target the
plasma membrane where they form
caveolae and interact with ion channels
The cav-3 protein is essential for proper assembling of membrane caveo-
lae. There are so far few and discordant pieces of evidence concerning the
membrane localization of the T78M cav-3 isoform. Immunostaining of
T78M cav-3-transfected COS-7 cells showed a distribution pattern similar
to that of WT cav-3-transfected cells.10 In another study, however, immu-
nostaining of a muscle biopsy of a patient carrying the T78M variant re-
sulted in a very faint cav-3 signal in most fibres.11 Here, using a cell model
without endogenous caveolins, we have shown that the T78M cav-3, like
the WT isoform, is expressed at the plasma membrane (Figure 1A). The
presence of caveolins in the plasma membrane is a necessary but not suffi-
cient condition to generate the caveolar domain. Therefore, taking advan-
tage of the cellular system lacking caveolae, we analysed the presence of
caveolae using electron microscopy in the presence of either the WT or
the T78M cav-3. No evident differences in the ability of the system to form
caveolae and in the number of caveolae produced in the two conditions
were observed. These data elucidate for the first time not only that T78M
cav-3 targets the plasma membrane but also that its expression still per-
mits the generation of caveolar structures. Despite this, the functional in-
tegrity and molecular composition of the caveolar microdomains cannot
be determined based only on the evidence of membrane expression.
The interaction of cav-3 with the proteins residing in the caveolar do-
main is a determinant of their functionality. To address the functional role
of T78M cav-3 in a cardiac context, we focused our attention on two
channels, hKv1.5 and hHCN4, which are dysregulated in several cardiac
pathologies32–35 and are known to interact with caveolins. Folco and col-
leagues23 demonstrated that hKv1.5 interacts with cav-3 through the bind-
ing of SAP-97, whereas, we have previously shown that mutations in the
caveolin binding domain of HCN4 alter both functional properties and
trafficking of this channel to the plasma membrane.22 Results obtained
with discontinuous sucrose gradient and co-immunoprecipitation experi-
ments show that both channels localize to lipid rafts and are able to inter-
act with both the T78M and WT cav-3 (Figure 2). It is thus likely that also in
the presence of the T78M cav-3 the channels reside in caveolae.
......................................................................................................
Table 1 Frequencies of the 233C>T Single Nucleotide
Polymorphism in the cohorts investigated in this work and
in the general population
Pathology Allele
count/number
Allele
frequency
Inappropriate sinus tachycardia 4/92* 4.35%
Atrial fibrillation 2/32* 6.25%
Stillbirth 2/74* 2.7%
Sinus bradycardia 1/222 0.45%
Unaffected controls 0/418 0%
General population (ExAC) 367/120800 0.3%
*P< 0.05 by Fisher’s exact test.
Figure 6 Mathematical models of both atrial and sinoatrial cells show
an arrhythmic contribution of the T78M cav-3. Atrial (top) and sino-
atrial (bottom) action potentials generated using the Grandi-Bers
human atrial cell model19 and the Severi-DiFrancesco rabbit sinoatrial
cell model,20,21 respectively. Thin line, basal conditions (WT); thick line,
after insertion of the T78M cav-3-dependent alterations.
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4.3 The T78M variant induces functional
changes in membrane excitability by
affecting ion channel function
While still maintaining an interaction with the channels, T78M cav-3
induces significant alterations of their functional properties. Indeed, elec-
trophysiological analysis revealed that it induces a leftward shift in the ac-
tivation curves of hKv1.5 channels and a rightward shift in the activation
curves of hHCN4 channels in MEF-KO cells. This suggests an increased
contribution of both currents during an action potential. In agreement
with the proper interaction of channels with T78M cav-3, proteins traf-
ficking to the plasma membrane and thus current densities were not
altered.
Despite the previously reported effects of the T78M cav-3 variant on
Nav1.5 and on Kir2.1 channels,9,13 and the effects on HCN4 and Kv1.5
channels reported here, the overall action on membrane excitability is
difficult to predict. NRVC express all the above ion channels36–38 and
modulatory proteins,18 among which cav-1, that may form oligomers
with cav-3.25 Moreover, they also possess all the calcium-handling pro-
teins that contribute to membrane excitability and are modulated by cav-
eolae.26 Transfection of the T78M cav-3 variant in NRVCs allowed us to
estimate its effect on all these endogenous proteins modulated by cav-3.
While the expression of the human WT cav-3 in NRVCs did not affect
cell excitability, the expression of the T78M cav-3 caused a clear modifi-
cation of CVIBI and SDMDP. Notably, neonatal cardiomyocytes show an
endogenous If current that, according to our data, was activated in a volt-
age range significantly more positive in T78M than in the WT cav-3 trans-
fected cells (see Supplementary material online, Figure S1), indicating that
alterations in ion channels observed in MEF-KO cells are maintained.
Nonetheless, the alterations observed in the presence of T78M cav-3 on
membrane excitability do not reproduce the expected effect on a single
current, but are the result of the modification of many factors contribu-
ting to the integrated electrical activity of cardiomyocytes.
4.4 In silico analysis confirms that the
T78M cav-3 alters the action potential
shape of atrial and sinoatrial cells
As an alternative approach to evaluate the effect of the T78M on the
electrical properties of specific types of cardiomyocytes, we carried out
in silico analysis by modelling the alteration in ion currents reported here
and in previous works. In this regard, in our analysis we omitted the ef-
fect of the T78M mutation on Kir2.1 channels13 because (1) the 70% de-
crease in IK1 shown by Vaidyanathan et al.
13 was not compatible with the
generation of action potentials in the atrial models tested (see
Supplementary material online, Figure S2A) and (2), we failed to detect
any T78M-dependent downregulation of either Kir2-1 channels trans-
fected in MEF-KO cells (see Supplementary material online, Figure S2B)
or of endogenous IK1 current in neonatal cardiomyocytes (not shown).
We are unable to provide an explanation for this discrepancy. Even in
the absence of any modification of the IK1 current, our simulations clearly
show that action potentials of both rabbit sinoatrial and human atrial
cells are significantly altered. In particular, a reduction of the atrial action
potential duration and a more positive activation of HCN channels, such
as those we observed, are both involved in the remodelling associated
with atrial fibrillation.29,34 Moreover, a gain of function of HCN4 induces
a faster rhythm in SAN cells, a condition compatible with phenotypic
manifestations of inappropriate sinus tachycardia.28 Although in neonatal
cardiomyocytes the overexpression of the T78M cav-3 gives rise to a
positive shift of the native If current (see Supplementary material online,
Figure S1) we did not see the increase in firing rate, as observed in the
SAN model. This discrepancy may occur because NRVCs do not repre-
sent a model of SAN cells. Indeed, they have much lower If current dens-
ity17 than either rabbit3 or mouse SAN.39 Furthermore, they express the
IK1 current, which counteracts the If-dependent membrane depolariza-
tion. Not surprisingly, therefore, the effect of T78M cav-3 on If has lim-
ited impact on NRVC firing rate. Finally, the computational model
reproduces a single cell, which includes only known effects on single cur-
rents, whereas data from cardiomyocytes were obtained from small
clusters of cells in which all the mechanisms, directly or indirectly af-
fected by the mutation, are working.
4.5 Study limitations
The results of the genetic analysis performed on arrhythmic patients is
limited by the sample size and an extended analysis would be necessary
to possibly correlate the T78M cav-3 variant with the pathological condi-
tions studied.
Another limitation of the present study is that our experiments were
all based on transient transfection of either the WT or mutated cav-3, an
approach that does not allow to control levels of expression. An alterna-
tive and more sophisticated approach to study the effect of the T78M
variant would be to generate induced pluripotent stem cells from pa-
tients and differentiate them into functional cardiomyocytes. This ap-
proach is at this moment unfeasible in our lab because of the lack of
patient-derived cells to reprogram.
5. Conclusions
Our data provide the first evidence that the mutant T78M cav-3 nor-
mally reaches the plasma membrane and generates caveolae, yet it modi-
fies at the same time the functional properties of the interacting
pacemaker hHCN4 channels and the atrial-specific hKv1.5 channels,
both important for the physiological activity of sinoatrial and atrial cells,
respectively. Moreover, we show that the presence of the T78M cav-3
can significantly alter the overall electrical activity both in vitro in spontan-
eously beating cardiomyocytes and in silico in atrial and sinoatrial cell
models. These data, together with the observation that the T78M variant
is found more frequently in patients with rhythm disorders, suggest that
the presence of the T78M variant, through alteration of the functional
contribution of multiple ion channels can, under specific conditions, pre-
dispose to initiation of life-threatening arrhythmias.
Supplementary material
Supplementary material is available at Cardiovascular Research online.
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